Surveillance after curative colon cancer resection: Practice patterns of surgical subspecialists
- 21 Downloads
Background: In the literature, suggested strategies for the follow-up of colon cancer patients after potentially curative resections vary widely. The optimal regimen to monitor for recurrences and new primary tumors remains unknown. The nationwide cost impact of wide practice variation is also unknown.
Methods: The 1,070 members of The Society of Surgical Oncology (SSO) were surveyed using a detailed questionnaire to measure the practice patterns of surgical experts nationwide. Respondents were asked how often they use nine separate methodologies in follow-up during years 1–5 postsurgery for TNM stage I, II, and III patients. Costs were estimated for representative less and more intensive strategies.
Results: Evaluable responses were received from 349 members (33%). Office visit and carcinoembryonic antigen analysis were performed most frequently. SSO members generally see patients every 3 months in years 1–2, every 6 months in years 3–4, and annually thereafter. There was wide variability in test ordering patterns and moderate variation between SSO and previously surveyed American Society of Colon and Rectal Surgeons members. The charge differential between representative less and more intensive follow-up strategies for each annual U.S. patient cohort is ∼$800 million.
Conclusions: Actual practice patterns vary widely, indicating lack of consensus regarding optimal follow-up. The enormous cost differential associated with such variation is difficult to justify because there is no proven benefit of more intensive follow-up.
Key WordsFollow-up Colon cancer Cost analyses
Unable to display preview. Download preview PDF.
- 2.Waye J, Lewis B, Yessayan S. Colonoscopy, a prospective report of complications.Gastrointest Endosc 1990;36:226.Google Scholar
- 6.Steele G Jr. Follow-up plans after curative resection of primary colon or rectum cancer. In: Steele G, Osteen RT, eds.Colorectal cancer. New York: Marcel Dekker, 1986.Google Scholar
- 9.Buie WD, Rothenberger DA. Surveillance after curative resection of colorectal cancer.Gastrointest Endosc Clin North Am 1993;3:691–713.Google Scholar
- 11.GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial.JAMA 1994;271:1587–92.Google Scholar
- 14.Health Care Financing Administration. Part B Medicare Annual Data (BMAD) file, 1992.Google Scholar
- 15.Health Care Financing Administration. Medicare Hospital Outpatient Bill (HOP) file, 1992.Google Scholar
- 17.American Cancer Society.Cancer Facts & Figures—1993.Google Scholar
- 18.Miller BA, Ries LAG, Hankey BF, Kosary CL, Edwards BK, eds.Cancer Statistics Review: 1973–1989. Table VI-7, National Cancer Institute. NIH Publication No. 92-2789, 1992.Google Scholar
- 22.Ovaska J, Jarvinen H, Kujari H, Pertilla I, Mecklin JP. Surveillance after colon cancer: is it worthwhile?Gastroenterology 1990;99:1849–51.Google Scholar
- 23.Wagner JS, Adson MA, van Heerden JA, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer.Ann Surg 1984;199:512–8.Google Scholar